At the conclusion of the order period, there were total orders of $514 million, well in excess of the amount offered, and indicative of investor sentiment towards the credit-worthiness of the North Broward Hospital District, which operates as Broward Health. As a result of the significant investor demand for the Bonds, Broward Health was able to secure long-term fixed rate borrowing at a very low true interest cost of 4.24 percent.
The proceeds of the Series 2017B Bonds are being utilized to fulfill multiple Broward Health objectives, including funding for capital investments into signature projects such as expansion of the Salah Foundation Children's Hospital at Broward Health. Bond proceeds will also mitigate the risk to Broward Health’s balance sheet by refinancing variable debt with long-term fixed rate borrowing. They will also enhance Broward Health’s unrestricted cash balances.
"Achieving an appropriate level of permanence to the capital structure of Broward Health is vital to its financial stability and ability to fulfill its mission,” said Christopher T. Ure, North Broward Hospital District Board Vice Chair. Ure, who has more than 25 years of experience in the investment banking and financial services industries, said he was pleased with the results of the bond issuance. "The overwhelming interest the market has shown in this offering is recognition of the strength of Broward Health, the critical role it plays in our community, and the level of confidence the market has in our management team and board.”
Broward Health Interim President/CEO Beverly Capasso said, “The bond sale is a significant milestone in our turnaround and transformation. It means a positive prognosis for the future of Broward Health.”
Broward Health Chief Financial Officer Alan Goldsmith said, “This excellent pricing and sale result is the culmination of several months of careful planning and strategic decision-making and is another step in ensuring the financial stability of Broward Health for the foreseeable future.”